Biotechnology

#AI #Biotechnology #Technology

This week in drug discovery (4-8 April) 

News round-up by DDW’s Megan Thomas for 4-8 April   When considering trends in the drug discovery industry, the use of technology to advance treatments and therapeutics is consistently observed. DDW rounds up five of this week’s top news stories which reveal this theme of technology, AI and… Read More

#News

#AI / data analytics / healthtech / informatics #Biotechnology #Drug discovery #Podcast

Scientific data management: What does your lab need? – podcast

This is the latest episode of the free DDW podcast, “Scientific data management: What does your lab need?”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 and Volume 22, Issue 4 – Fall 2021 of DDW.   The articles are… Read More

#News

#Analysis #Biotechnology #Health #Life sciences

Listicle: Lithuania’s biotechnology growth strategy

Lithuania is dedicating time and resources establishing itself as a life science and biotechnology hub of excellence. DDW’s Megan Thomas analyses four pillars of Lithuania’s growth strategy, which involves ensuring female scientists take leading roles in industry, focusing on investment, developing a strong talent pool as well establishing itself as a… Read More

#Editor's Choice #Exclusive Content #Listicles #News #Videos

#AI / data analytics / healthtech / informatics #Biotechnology #Collaboration

This week in drug discovery (21-25 February) 

News round-up by DDW’s Megan Thomas for 21-25 February, 2022  This week’s drug discovery news reflects breakthroughs across therapeutic areas with a focus on collaboration not just between scientists and institutions, but also businesses and regulatory organisations. 1. New human beta cell model enables discoveries in… Read More

#News

#AAV #Biotechnology #Diabetes #Precision medicine

Collaboration to develop AAV vectors for diabetes gene therapy 

PerkinElmer’s SIRION Biotech business and the Centre for Genomic Regulation (CRG) have agreed to jointly develop new generation adeno-associated virus (AAV) vectors for Type 1 and Type 2 diabetes gene therapy in the pancreas.  The collaboration  The collaboration combines SIRION’s AAV technology platform and expertise… Read More

#News

#Biotechnology #mRNA

eTheRNA research agreement with Merck to access mRNA technologies 

eTheRNA immunotherapies has partnered with Merck to investigate the application of eTheRNA’s mRNA design expertise and LNP-delivery platforms to disease areas selected by Merck.  Context   The ongoing pandemic has underlined the capability for mRNA vaccines as a new therapeutic modality. eTheRNA and Merck both recognise… Read More

#News

#Biochemistry #Biotechnology #DNA #Drug targets

New solution to accelerate repair genome editing research 

Integrated DNA Technologies (IDT) has released Alt-R HDR Donor Blocks, a solution for increasing homology-directed repair (HDR) rates in large fragment knock-in experiments.   How does Alt-R HDR work?  The Alt-R HDR Donor Blocks incorporate advanced chemical modifications to boost the HDR rates of large genomic… Read More

#News

#Biotechnology #DNA #Drug discovery #mRNA #Synthetic chemistry

From synthetic biology to synthesising DNA: helping advance research 

Evonetix is reimagining biology. Dr Vijay Narayan, Head of Physics, Dr Stuart Crosby, Head of Synthetic Chemistry, and Daniel Bygrave, Principal Software Engineer, offer insight into the technology being developed by the company and its relevance for researchers.  "I have always been intrigued by interdisciplinary environments,’ says Dr Vijay Narayan, Head of Physics, Evonetix. “This is… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Intelligence #News #Trends & Analysis

#AI / data analytics / healthtech / informatics #Biotechnology #Clinical trials #Comment #Data science #Decentralised clinical trials #Digital

Predictions and perspectives on the future of DCTs 

"The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions", says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.  Clinical trials are now more complex than ever, and sites and… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Biotechnology #Drug discovery #eBook #Lab automation

eBook: Your essential guide to drug discovery technology

This 28-page DDW eBook, sponsored by Bio-Rad, contains exclusive insight from industry experts on what’s new in lab automation and how this technology can accelerate your drug discovery process and is available to download now. With this guide, you can learn more about: The benefits of automation and how to… Read More

#News #Trending News

#Antigen #Biotechnology #Immunology / Virology & Vaccines #mRNA #RNA #Therapeutics

What’s next for RNA-based medicine post-Covid-19?

Dr Pirkko Muhonen, Senior Field Application Scientist, Nucleic Acid Therapeutics, at Thermo Fisher Scientific, shares what's next for RNA-based medicine post-pandemic with DDW. With SARS-CoV-2 circulating the globe and leading to over five million deaths worldwide1, all eyes are on the critical role messenger RNA (mRNA) vaccines are playing in… Read More

#Covid-19 #Exclusive Content #News #Trends & Analysis

#Analysis #Biotechnology #Health #Life sciences

Four pillars of the Lithuanian life sciences growth strategy 

Click here to watch this as a video Lithuania is dedicating time and resources establishing itself as a life sciences and biotechnology hub of excellence. DDW’s Megan Thomas analyses four pillars of Lithuania’s growth strategy, which involves ensuring female scientists take leading roles in industry, focusing on investment, developing a strong… Read More

#Editor's Choice #Exclusive Content #News #Trends & Analysis

#Biotechnology #Cell and gene therapy #Collaboration

Collaboration leads to new centre for cell therapy manufacturing 

Orgenesis, a global biotech company working with cell and gene therapies, and The Johns Hopkins University in the US, have collaborated to construct a cell and gene therapy processing facility for point of care treatment of patients at Johns Hopkins which is planned to start in the second quarter of… Read More

#News

#AI / data analytics / healthtech / informatics #Bioinformatics #Biopharmaceuticals #Biotechnology #Collaboration

Scitara joins collaboration to drive biopharmaceutical advancements  

Scitara has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements.  The Lab of the Future  Scitara joins BioPhorum Information Technology, which aims to accelerate digital maturity across the global biomanufacturing industry. One of the programmes within the portfolio,… Read More

#News

#Biotechnology #Clinical trials #Imaging

Industry predictions for clinical trials 

Medidata reflects on how clinical trials have evolved over the past year, as well as emerging patterns and drivers of change for the coming year. Paul O’Donohoe and Fiona Maini from Medidata explain.  1. The future of clinical trials is decentralised  Decentralised clinical trials, described as the ‘new normal’ in clinical research, harness remote technologies to… Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Trends & Analysis